Cargando…

Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease

The incidence of inflammatory bowel diseases (IBD) is rising worldwide. The therapeutic options for IBD are expanding, and the number of drugs with new targets will rapidly increase in coming years. A rapid step-up approach with close monitoring of intestinal inflammation is extensively used. The fe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran-Minh, My-Linh, Sousa, Paula, Maillet, Marianne, Allez, Matthieu, Gornet, Jean-Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424291/ https://www.ncbi.nlm.nih.gov/pubmed/28539989 http://dx.doi.org/10.4254/wjh.v9.i13.613

Ejemplares similares

Cephalic Duodenopancreatectomy for Hyperalgic Duodenal Crohn's Disease Fistulized in the Pancreatic Gland
por: Guellouz, Sabra, et al.
Publicado: (2014)

Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease
por: Nguyen, Huyen-Tran, et al.
Publicado: (2017)

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
por: Dotan, Iris, et al.
Publicado: (2019)

Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn’s Disease
por: Hammoudi, Nassim, et al.
Publicado: (2022)

Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
por: Richette, Pascal, et al.
Publicado: (2022)

Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
por: Axiaris, Georgios, et al.
Publicado: (2021)

Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive Therapy
por: Kounis, Ilias, et al.
Publicado: (2023)

Prevalence of Fatigue and Unrecognized Depression in Patients with Inflammatory Bowel Disease in Remission under Immunosuppressants and Biologicals
por: Truyens, Marie, et al.
Publicado: (2021)

Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease
por: Cao, Yuan, et al.
Publicado: (2015)

IMPROVING THE VACCINATION RATES FOR IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Cheng, Tony, et al.
Publicado: (2022)

Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments
por: Maillet, François, et al.
Publicado: (2021)

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
por: Park, Jihye
Publicado: (2022)

Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy
por: Barberio, Julie, et al.
Publicado: (2020)

Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis
por: Schleker, Teresa, et al.
Publicado: (2018)

A Case of Renal Inflammatory Pseudotumor Leading to Nephrectomy
por: Tuan Linh, Le, et al.
Publicado: (2021)

Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS
por: Lelong, Margaux, et al.
Publicado: (2022)

Ocular Complications of Inflammatory Bowel Disease
por: Mady, Rana, et al.
Publicado: (2015)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Enterocytozoon Bieneusi Infects Children With Inflammatory Bowel Disease Undergoing Immunosuppressive Treatment
por: Zajączkowska, Żaneta, et al.
Publicado: (2021)

Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation
por: Singh, Urvashi, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study
por: Wasserbauer, Martin, et al.
Publicado: (2022)

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
por: García, María José, et al.
Publicado: (2021)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy
por: Shirai, Shimpei, et al.
Publicado: (2018)

Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
por: Giagkou, Eftychia, et al.
Publicado: (2018)

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

The risk of cardiovascular complications in inflammatory bowel disease
por: Czubkowski, Piotr, et al.
Publicado: (2020)

What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?
por: Gornet, J.-M., et al.
Publicado: (2020)

Que doivent savoir les chirurgiens à propos des troubles digestifs et des anomalies paracliniques induits par le COVID 19 ?()
por: Gornet, J.-M., et al.
Publicado: (2020)

Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study()
por: Malamut, Georgia, et al.
Publicado: (2013)

The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence
por: Zhang, Mengyuan, et al.
Publicado: (2021)

Percutaneous embolization of hepatic lymphorrhea post-hepatectomy
por: Dung, Le Viet, et al.
Publicado: (2021)

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
por: Calafat, Margalida, et al.
Publicado: (2021)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Biologic Concentration Testing in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2015)

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study
por: Amiot, Aurelien, et al.
Publicado: (2022)

Inflammatory bowel disease and pregnancy: fertility, complications and treatment
por: Ali, Mohammad Fahad, et al.
Publicado: (2020)

MicroRNAs in Inflammatory Bowel Disease and Its Complications
por: Krishnachaitanya, Srikruthi S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lui0b2fcimmno7p5cq9t36bck4